TABLE 1.

Anti‐tumour activity in patients.

Variable	Immunotherapy (N = 58)	Chemotherapy plus immunotherapy(N = 32)	Chemotherapy (N = 27)
Overall response rate	46.5%	50.0%	37.0%
Response Group
R	27	11	13
NR	31	21	14

Note: Responders were defined as best response is complete response (CR), partial response (PR) or stable disease (SD) and lasts more than 6 months. Non‐responders were defined as best response is progressive disease or CR/PR/SD lasts less than 6 months. Overall response was defined as a confirmed CR or PR.

Abbreviations: NR, non‐responders; R, responders.